Friday, April 19, 2024
Advertisement
Updated on: May 09, 2021 13:40 IST

Jeetega India: How Parents can protect their children from Upcoming wave of COVID-19? Experts Explains

anti-COVID-19 therapeutic application of 2-DG drug has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a leading laboratory of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy's Laboratories (DRL) in Hyderabad.

Latest Videos

Advertisement
Advertisement
Advertisement
Advertisement